医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Asia MannaFest Sets the Tone for Mannatech’s Expansion Plans

2015年10月23日 AM01:00
このエントリーをはてなブックマークに追加


 

SEOUL, South Korea

Mannatech, Incorporated (NASDAQ: MTEX), the founder of the M5M (Mission 5 Million) Foundation, the pioneer of nutritional glycobiology and the global innovator of naturally sourced supplements based on Real Food Technology® solutions, is expecting more than 10,000 attendees at its annual Asia MannaFest℠ event at Jamsil Olympic Park on October 31. As Mannatech’s largest global event, thousands will gather to share their boundless enthusiasm for the wellness and entrepreneurial opportunities the company offers throughout Asia.

Mannatech’s growing presence in Asia will be on full display as the event brings together Mannatech independent sales Associates and leaders from numerous countries and cities, including Korea, Hong Kong, Japan, Taiwan, Singapore and South Africa. The sales Associates will share recognition, acknowledge business builders and celebrate a year’s worth of success. Asia is leading Mannatech’s global expansion as the region’s increasingly prosperous population makes health, wellness, nutrition and fitness a priority.

“Asia MannaFest will be a life-changing event for many of the thousands who attend,” said Mannatech CEO and President Al Bala. “Our operations in Asia, specifically in Korea, are at the heart of Mannatech’s global success. Our teams in Asia continue to set a magnificent pace for innovation and professionalism for Mannatech and all other direct sales companies.”

Asia MannaFest will be hosted by Mannatech Korea and led by Patrick Park, Mannatech’s Regional President of Asia. Park has been instrumental in Mannatech’s rapid growth in the region, and will serve as the dynamic master of ceremonies at the Asia MannaFest event.

“We are extremely proud of the amazing effort our sales Associates demonstrate on a daily basis, and this event is just a small indication of the excitement Mannatech is generating in Asia,” said Park. “Asia MannaFest is an event unlike any other. It is proof that Mannatech is a force in this region because of its ability to attract thousands of independent sales Associates, who represent hundreds of thousands of satisfied customers whose lives have been impacted by Mannatech’s products.”

As an extra highlight, Mannatech will be launching its new product, Cognitate™, exclusively in Korea at Asia MannaFest. Cognitate is a brain health supplement designed to help improve cognitive ability. It helps to improve memory and protects against age-related cognitive decline.* Cognitate is designed for Korean families with older members, busy parents, business professionals and high-achieving students.

In addition, for the first time ever, Mannatech’s entire Board of Directors will make the trip to Asia to tour Mannatech’s Asia Regional Offices, underscoring the Asia-Pacific market’s prominent role in the company’s international expansion.

Asia MannaFest special guests and speakers include Al Bala; Global Wellness Director, Steve Nugent; and M5M℠ Foundation Executive Director, Sarah Bowen.

Registration and General Sessions will begin on Saturday, October 31 at 9 a.m. in the Exhibition Zone of the SK Handball Stadium in Olympic Park.

The event will kick off on Friday, October 30 at 5 p.m. with a special dinner party to honor the accomplishments of select Mannatech Asia sales Associates.

For more information, please visit http://www.mannatech.co.kr/amf2015/en/.

About Mannatech

Mannatech, Incorporated, develops high-quality health, weight and fitness, and skin care products that are based on the solid foundation of nutritional science and development standards. Mannatech is dedicated to its platform of Social Entrepreneurship based on the foundation of promoting, aiding and optimizing childhood nutrition where it is needed most around the world. Mannatech’s proprietary products are available through independent sales associates around the globe including the United States, Canada, South Africa, Australia, New Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan, Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech Republic, the Republic of Korea, Mexico, Namibia, Spain and Hong Kong. For more information, visit Mannatech.com.

Please note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain associates and members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151022005981/en/

CONTACT

Mannatech, Incorporated
Kalyn Ballard, 972-471-7245
pr@mannatech.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Clover Biopharmaceuticals Completes RMB 62.8 Million Series A Financing
  • 三叶草生物制药完成6,280万元人民币A轮融资
  • Corindus Announces First Commercial Installation of CorPath® GRX System Outside of U.S.
  • Walmart, JD.com, IBM and Tsinghua University Launch a Blockchain Food Safety Alliance in China
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-402の第I相中間データを発表